Products

PeraMobile and PeraWatch
PeraHealth (acquired by Spacelabs Healthcare)
Clinical Decision Support & Reference
PeraHealth, now part of Spacelabs Healthcare, offers predictive analytics solutions like PeraMobile and PeraWatch, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs.

See all 1 product →

About PeraHealth (acquired by Spacelabs Healthcare)

PeraHealth, acquired by Spacelabs Healthcare in February 2023, was a healthcare AI company specializing in predictive analytics. Its core offering was the Rothman Index, an FDA-cleared predictive enterprise software designed to quantify patient acuity. This proprietary algorithm leverages existing electronic medical record (EMR) data, including physiological measures, labs, and nursing assessments, to generate a single, continuous score reflecting a patient’s condition over time.

For physicians, PeraHealth’s solutions provided real-time and predictive analytics to identify at-risk patients sooner, enabling earlier intervention. The Rothman Index offered a visual dashboard of a patient’s condition, alerting clinicians to subtle deterioration and helping to reduce in-hospital mortality, unplanned transfers to the ICU, and facilitating more timely palliative care consults. The platform aimed to transform the clinical and financial efficiency of healthcare by improving quality and reducing costs through intelligent data utilization.

Post-acquisition, PeraHealth’s predictive analytics capabilities, particularly the Rothman Index, have been integrated into Spacelabs Healthcare’s clinical informatics solutions, further expanding Spacelabs’ digital health portfolio. Joseph Beals, the former CEO of PeraHealth, now leads Spacelabs’ data science strategy, ensuring the continued development and application of these advanced analytics.

Focus Areas

Predictive analytics real-time clinical surveillance patient acuity patient deterioration sepsis detection ICU optimization palliative care consults reducing in-hospital mortality reducing unplanned ICU transfers clinical decision support data technology platform SaaS HealthTech

Business Intelligence

Key InvestorsMainsail Partners, Keiretsu Forum
PartnershipsCaregility, Shannon Health, Yale New Haven Health System, Houston Methodist, Children's Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, Mission Health
AcquisitionsAcquired by Spacelabs Healthcare (February 16, 2023)
TechnologyRothman Index (proprietary algorithm/model), EHR integration, Google Cloud-based, SaaS, real-time and predictive analytics
FDA Clearances2+ cleared products (estimated)

What Physicians Need to Know

Specialization: Predictive Analytics & Clinical Surveillance
PeraHealth, now part of Spacelabs Healthcare, specializes in real-time predictive analytics and clinical surveillance. Their core offering, the Rothman Index, quantifies patient acuity and alerts clinicians to early signs of patient deterioration, including sepsis detection.
Key Differentiator: The Rothman Index
The Rothman Index is highlighted as the only FDA-cleared predictive analytics solution of its kind on the market and the only general measure of patient condition. It leverages a heuristic model that synthesizes existing Electronic Health Record (EHR) data, including vital signs, lab results, and crucially, nursing assessments, to provide a continuous, real-time measure of patient health.
Impact on Patient Outcomes
Their solutions are designed to reduce in-hospital mortality (with reported reductions of up to 30%), decrease unplanned ICU transfers, optimize ICU utilization, and facilitate more timely palliative care consults.
Technology Platform
PeraHealth operates as a SaaS (Software-as-a-Service) company, offering predictive enterprise software. The platform utilizes machine learning and proprietary algorithms based on the Rothman Index to deliver actionable insights at both the patient and population levels.
Physician Tip

For physicians, PeraHealth's solutions, powered by the Rothman Index, stand out by providing a clear, visual dashboard of a patient's condition in real-time, across all care settings and diagnoses. This enables early detection of subtle patient deterioration, allowing for proactive intervention before conditions become life-threatening. The system integrates seamlessly with existing EHRs, utilizing current data without requiring additional documentation, thereby streamlining workflows and providing critical clinical decision support to improve patient safety and outcomes.

PeraHealth's solutions are designed for integration with major EHR vendors, notably joining Epic's App Orchard to enable seamless data flow via APIs. They also engage in partnerships, such as with Caregility, to integrate virtual care platforms for direct patient engagement and telemedicine capabilities.

Products by PeraHealth (acquired by Spacelabs Healthcare)

1 product in the directory

PeraMobile and PeraWatch
PeraHealth (acquired by Spacelabs Healthcare)
Clinical Decision Support & Reference
PeraHealth, now part of Spacelabs Healthcare, offers predictive analytics solutions like PeraMobile and PeraWatch, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs.

Reviews & Opinions

No web reviews on file yet for PeraHealth (acquired by Spacelabs Healthcare). Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about PeraHealth (acquired by Spacelabs Healthcare).

Loading videos...

Videos load interactively. If none appear, search YouTube for PeraHealth (acquired by Spacelabs Healthcare) →

View all on YouTube

Press & Coverage

Spacelabs Healthcare
Spacelabs Healthcare Expands Clinical Informatics Capabilities with Acquisition of Predictive Analytics Company PeraHealth
Spacelabs Healthcare announced its acquisition of PeraHealth, developer of the FDA-cleared Rothman Index, a predictive analytics solution that quantifies patient acuity and alerts clinicians to deterioration in real-time. This acquisition aims to integrate PeraHealth's analytics into Spacelabs' digital health portfolio to improve patient outcomes and reduce costs.
2023-02
DOTmed
Spacelabs Healthcare acquires predictive analytics company PeraHealth
Spacelabs Healthcare has acquired PeraHealth, the company behind the Rothman Index, a predictive enterprise software that quantifies and alerts clinicians to patient deterioration. The acquisition aims to combine their technologies to facilitate better outcomes and decrease costs in healthcare organizations.
2023-02
Research Live
Spacelabs acquires predictive analytics business
Medical equipment manufacturer Spacelabs Healthcare has acquired PeraHealth, a predictive analytics company known for its Rothman Index, a score used to quantify patient acuity. Joseph Beals, former CEO of PeraHealth, will now lead data science strategy at Spacelabs.
2023-03
MrWeb
Spacelabs Buys Predictive Analytics Firm PeraHealth
Spacelabs Healthcare has acquired PeraHealth for an undisclosed sum, integrating PeraHealth's FDA-cleared Rothman Index into its digital health portfolio. The Rothman Index uses EMR data to provide actionable insights at both patient and population levels.
2023-03
Business Wire
Spacelabs Healthcare Announces Agreement to Provide its Rothman Indexu00ae to Hospitals and Health Systems Through DEPTH Health
Spacelabs Healthcare has partnered with DEPTH Health to offer its Rothman Index through DEPTH's Real-Time Advisor for Clinical Expert Routing (RACERu2122) platform. This collaboration aims to help healthcare providers identify subtle changes in patient conditions and optimize patient traffic flow.
2026-04
Spacelabs Healthcare
Peer-reviewed articles and abstracts
This page provides a collection of peer-reviewed articles and abstracts related to the Rothman Index, showcasing academic research on its effectiveness in patient condition monitoring and predicting outcomes.
unknown
Spacelabs Healthcare
Spacelabs Healthcare Receives Innovative Technology Designation from Vizient for the Rothman Index
Spacelabs Healthcare's Rothman Index clinical decision support system received an Innovative Technology designation from Vizient, Inc., recognizing its predictive analytics technology for improving healthcare performance.
unknown

Frequently Asked Questions

The Rothman Index (RI) is an FDA-cleared predictive enterprise software that quantifies patient acuity by analyzing real-time data from electronic health records, including vital signs, lab results, and nursing assessments. It provides clinicians with a visual dashboard (PeraTrend) to detect subtle, potentially life-threatening changes in a patient's condition, often with less than 24 hours' warning, enabling early intervention.
The Rothman Index is a novel approach to sepsis screening and prediction, enhancing the ability to detect sepsis, severe sepsis, or septic shock by identifying patients at risk through general physiological deterioration. Its early warning capabilities provide clinicians with more time to intervene, which is crucial for improving outcomes in sepsis cases and reducing associated mortality.
PeraHealth's solutions are proven to help reduce in-hospital mortality and decrease unplanned transfers to the ICU. For instance, some implementations have shown a 16% decrease in mortality rates and a 30% reduction in unplanned ICU transfers, contributing to improved patient safety and optimized resource utilization within the ICU.
The Rothman Index provides accurate, actionable insights as an FDA-cleared clinical decision support tool, helping clinicians make informed decisions about patient care. It also aids in identifying patients who could benefit from palliative care services sooner, leading to more timely consults and potentially reducing length of stay and healthcare costs.
The Rothman Index operates as a SaaS (Software-as-a-Service) platform, leveraging a proprietary algorithm that automatically synthesizes data from existing electronic health records (EHRs). It is designed for easy integration with all major EHR vendors, and can be accessed via web browsers, integrated directly into EHRs, or displayed on nursing unit dashboards, including a Google Cloud-based version.
PeraHealth was acquired by Spacelabs Healthcare in February 2023, and its core product, the Rothman Index, continues to be a key offering within Spacelabs' clinical informatics portfolio. The former CEO of PeraHealth now leads Spacelabs' data science strategy, indicating continued investment and support for the Rothman Index solutions.
The Rothman Index is an FDA-cleared predictive analytics solution, addressing significant regulatory compliance for healthcare technology. While specific pricing models are not publicly disclosed, interested organizations should contact Spacelabs Healthcare directly for detailed information on costs and implementation.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.